Aristotle Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $69.4M | Sell |
|
|||||
|
2025
Q2 | $62.6M | Sell |
|
|||||
|
2025
Q1 | $64.9M | Buy |
|
|||||
|
2024
Q4 | $54.2M | Sell |
|
|||||
|
2024
Q3 | $73.1M | Sell |
|
|||||
|
2024
Q2 | $69M | Buy |
|
|||||
|
2024
Q1 | $75.6M | Buy |
|
|||||
|
2023
Q4 | $65.4M | Buy |
|
|||||
|
2023
Q3 | $62.8M | Buy |
|
|||||
|
2023
Q2 | $61.2M | Buy |
|
|||||
|
2023
Q1 | $59.7M | Buy |
|
|||||
|
2022
Q4 | $55.7M | Buy |
|
|||||
|
2022
Q3 | $41.4M | Sell |
|
|||||
|
2022
Q2 | $77.3M | Buy |
|
|||||
|
2022
Q1 | $75.7M | Buy |
|
|||||
|
2021
Q4 | $73.3M | Buy |
|
|||||
|
2021
Q3 | $61.2M | Buy |
|
|||||
|
2021
Q2 | $60.6M | Buy |
|
|||||
|
2021
Q1 | $43.5M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $244K | Buy |
|
|||||
|
2017
Q4 | $221K | Sell |
|
|||||
|
2017
Q3 | $254K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $206K | Sell |
|
|||||
|
2014
Q4 | $233K | Hold |
|
|||||
|
2014
Q3 | $251K | Hold |
|
|||||
|
2014
Q2 | $292K | Hold |
|
|||||
|
2014
Q1 | $292K | Hold |
|
|||||
|
2013
Q4 | $292K | Hold |
|
|||||
|
2013
Q3 | $274K | Hold |
|
|||||
|
2013
Q2 | $273K | Buy |
|